Compared with non-bortezomib-based induction, a strong trend toward improved OS was observed with bortezomib-based induction.
← all excerpts
Efficacy and Safety of Novel Agent-Based Therapies for Multiple Myeloma: A Meta-Analysis.
2
—
—
The sentences
Similar results could be seen in the subgroup of thalidomide-based regimens without ASCT, but they did not reach statistical significance in thalidomide-based regimens with ASCT or lenalidomide-based regimens without ASCT, which might be attributed to the small sample size of included studies in these two subgroups and short follow-up periods [ 25 – 28 , 31 , 32 ].